Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis

被引:30
|
作者
Liang, Xueheng [1 ]
Yu, Xingyan [2 ]
Gao, Tianhu [1 ]
机构
[1] Peoples Hosp Chongqing Banan Dist, Dept Radiol, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Chongqing, Peoples R China
关键词
Breast neoplasms; Machine learning; Magnetic resonance imaging; Neoadjuvant therapy; ACCURACY; MRI;
D O I
10.1016/j.ejrad.2022.110247
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of this meta-analysis was to determine the diagnostic accuracy of machine learning (ML) models with MRI in predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer. Furthermore, we compared the pathologic complete response (pCR) prediction performance of ML + radiomics with that of a deep learning (DL) algorithm. Methods: A search for relevant studies published until December 20, 2021 was conducted in MEDLINE and EMBASE databases. The quality of the studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies -2 criteria. The I-2 value assessed the heterogeneity of the included studies as well as the decision to adopt a random effects model. The area under the receiver operating characteristic curves (AUC) was pooled to quantify the predictive accuracy. Subgroup analysis, meta-regression analysis, and sensitivity analysis were performed to detect potential sources of study heterogeneity. A funnel plot was used to investigate publication bias. The PROSPERO ID of our study was CRD42022284071. Result: Seventeen eligible studies encompassing 3392 patients were evaluated in the analysis. ML + MRI showed high accuracy (AUC = 0.87, 95% CI = 0.84-0.91) in predicting response to neoadjuvant therapy. In subgroup analysis, the AUC of the DL subgroup (AUC = 0.92, 95% CI = 0.88-0.97) was higher than that of the ML + radiomics subgroup (AUC = 0.85, 95% CI = 0.82-0.90) (P = 0.030). In the ML + radiomics subgroup, the studies using MRI combined with other parameters (clinical or histopathologic information; AUC = 0.90, 95% CI = 0.85-0.96) reported better performance than studies using only MRI parameters (AUC = 0.82, 95% CI = 0.78-0.86) (P = 0.009). Conclusions: ML applied to MRI enabled moderate accuracy in predicting pathological response to neoadjuvant therapy in patients with breast cancer. Furthermore, the meta-analysis showed that DL had higher predictive accuracy than ML + radiomics.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol
    Pathak, Mona
    Dwivedi, Sada Nand
    Deo, S. V. S.
    Thakur, Bhaskar
    Sreenivas, Vishnubhatla
    Rath, G. K.
    SYSTEMATIC REVIEWS, 2018, 7
  • [32] Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: A systematic review and meta-analysis
    Cullinane, Carolyn
    Shrestha, Amber
    Al Maksoud, Ahmed
    Rothwell, Jane
    Evoy, Denis
    Geraghty, James
    McCartan, Damian
    McDermott, Enda W.
    Prichard, Ruth S.
    EJSO, 2021, 47 (07): : 1507 - 1513
  • [33] Performance of Machine Learning Algorithms in Discriminating Spondyloarthritis Features on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
    Moon, Sun Jae
    Lee, Seulkee
    Kang, Seonyoung
    Kim, Hyungjin
    Lee, Jaejoon
    Kim, Jinseok
    Koh, Eun-Mi
    Hwang, Jinseub
    Cha, Hoon-Suk
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3724 - 3726
  • [34] Machine Learning Driven by Magnetic Resonance Imaging for the Classification of Alzheimer Disease Progression: Systematic Review and Meta-Analysis
    Battineni, Gopi
    Chintalapudi, Nalini
    Amenta, Francesco
    JMIR AGING, 2024, 7
  • [35] Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
    Marinovich, Michael L.
    Houssami, Nehmat
    Macaskill, Petra
    Sardanelli, Francesco
    Irwig, Les
    Mamounas, Eleftherios P.
    von Minckwitz, Gunter
    Brennan, Meagan E.
    Ciatto, Stefano
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (05): : 321 - 333
  • [36] Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
    Ignatiadis, M.
    Singhal, S. K.
    Desmedt, C.
    Haibe-Kains, B.
    Criscitiello, C.
    Loi, S.
    Andre, F.
    Piccart, M.
    Michiels, S.
    Sotiriou, C.
    CANCER RESEARCH, 2011, 71
  • [37] Neoadjuvant chemotherapy in invasive bladder cancer:: a systematic review and meta-analysis
    Abol-Enein, H
    Bono, AV
    Boyer, M
    Clarke, NW
    Coppin, CML
    Cortesi, E
    Goebell, PJ
    Groshen, S
    Hall, RR
    Horwich, A
    Malmström, PU
    Martinez-Piñeiro, JA
    Parmar, MKB
    Raghavan, D
    Roberts, JTG
    Sengelov, L
    Sherif, A
    Stewart, LA
    Stockle, M
    Sylvester, R
    Tierney, JF
    Torti, FM
    Vale, CL
    Wallace, DMA
    LANCET, 2003, 361 (9373): : 1927 - 1934
  • [38] The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
    Mao, Yan
    Qu, Qing
    Zhang, Yuzi
    Liu, Junjun
    Chen, Xiaosong
    Shen, Kunwei
    PLOS ONE, 2014, 9 (12):
  • [39] Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
    Minarikova, Lenka
    Bogner, Wolfgang
    Pinker, Katja
    Valkovic, Ladislav
    Zaric, Olgica
    Bago-Horvath, Zsuzsanna
    Bartsch, Rupert
    Helbich, Thomas H.
    Trattnig, Siegfried
    Gruber, Stephan
    EUROPEAN RADIOLOGY, 2017, 27 (05) : 1901 - 1911
  • [40] Prediction of Pathologic Complete Response by Ultrasonography and Magnetic Resonance Imaging After Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Zhang, Kai
    Li, Jiawei
    Zhu, Qian
    Chang, Cai
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2603 - 2612